Sanofi CEO Sparks Outrage in France in U.S. Vaccine Row

The transcript discusses the complexities of vaccine nationalism, highlighting the ethical and logistical challenges in distributing a COVID-19 vaccine. It explores the role of funding from different countries and the importance of manufacturing scale-up. The conversation also touches on the global equity of vaccine access and the responsibility of pharmaceutical companies to contribute to society by providing vaccines at cost during the pandemic.

What factors should be considered when discussing the funding of vaccine research and development?

In what ways can pharmaceutical companies demonstrate their value to society during a pandemic?